1-2 of 2
Clement Rocher
Close
Sort by
Journal Articles

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group

Zofia Gross, Urbain Tauveron-Jalenques, Gaspar Aspas Requena, Martin Carre, Mathieu Meunier, Emmanuelle Tavernier, Jérôme Cornillon, Amine Belhabri, Mauricette Michallet, Adrien Contejean, Natacha Mauz, Boullanger FOW HENG Nadine, Daciana Claudia Antal, Gian Matteo Pica, Dony Arthur, Clémence Santana, Clement Rocher, Mael Heiblig
Journal: Blood
Blood (2023) 142 (Supplement 1): 590.
https://doi.org/10.1182/blood-2023-187331
Published: 2023
Journal Articles

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Mohamad Mohty, MD PhD, Florent Malard, MDPhD, Anne Vekhoff, MD, Simona Lapusan, MD, Francoise Isnard, PhD, Evelyne D'Incan, Jerome Rey, MD, Colombe Saillard, MD, Xavier Thomas, MD, Sophie Ducastelle-Lepretre, MD, Etienne Paubelle, MD, Marie Virginie Larcher, MD, Clément Rocher, MD, Christian Recher, MD PhD, Suzanne Tavitian, MD, Francoise Huguet, MD, Anne-Sophie Michallet, MD PhD, Lila Gilis, MD, Pierre Peterlin, Patrice Chevallier, MD, Stephanie Nguyen-Quoc, MD, Emilie Plantamura, PhD PharmD, Lilia Boucinha, PhD, Cyrielle Gasc, PhD, Mauricette Michallet, MD PhD, Joel Doré, PhD, Ollivier Legrand, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1444.
https://doi.org/10.1182/blood-2018-99-112825
Published: 2018